TY  - GEN
AU  - Karnon,Jonathan
AU  - Delea,Thomas
AU  - Barghout,Vicki
TI  - Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective
SN  - 1618-7598
PY  - 2008///1030
KW  - Anastrozole
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Agents, Hormonal
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cost-Benefit Analysis
KW  - Female
KW  - Humans
KW  - Letrozole
KW  - Markov Chains
KW  - Neoplasm Recurrence, Local
KW  - Neoplasms, Hormone-Dependent
KW  - Nitriles
KW  - Postmenopause
KW  - Quality of Life
KW  - Randomized Controlled Trials as Topic
KW  - Tamoxifen
KW  - Triazoles
KW  - United Kingdom
KW  - epidemiology
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10198-007-0058-1
ER  -